/Companies

Alx Oncology

NASDAQ: ALXOUnicorn · $3B

Founded 2015 · Incorporated in Delaware · 64 employees on LinkedIn · 8 known investors

Find your way into Alx Oncology

Sign up to see every warm intro you have to Alx Oncology

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Alx Oncology team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

ALX Oncology develops therapies for cancer treatment, operating in the biotechnology and medical technology sectors.

Founders & leadership

Alx Oncology was founded in 2015 by Corey Goodman.

CGCorey Goodman
Corey GoodmanChairmanCo-founder and Managing Partner at venBio Partners
JLJason Lettmann
Jason LettmannChief Executive OfficerPartner at Morgenthaler

Investors · 8

Valuation · disclosed

Disclosed events
$3Bvaluation at IPODec 2020 · $76.00/share · 424B4
filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

Founder mafia

2 people who came through Alx Oncology went on to found or lead other companies.

Related companies · 3

Companies working in the same space as Alx Oncology.

Frequently asked questions

What does Alx Oncology do?
ALX Oncology develops therapies for cancer treatment, operating in the biotechnology and medical technology sectors.
Who founded Alx Oncology?
Alx Oncology was founded by Corey Goodman in 2015.
Who are Alx Oncology's investors?
Alx Oncology's investors include Lightstone Ventures, age1, Foresite Capital, HBM Healthcare Investments, HBM Partners, venBio Partners, Logos, Vivo Capital.